Skip to main content
Erschienen in: Annals of Surgical Oncology 6/2011

01.06.2011 | Thoracic Oncology

In-Hospital Mortality After a Surgical Resection for Esophageal Cancer: Analyses of the Associated Factors and Historical Changes

verfasst von: Masaru Morita, MD, PhD, FACS, Tomonori Nakanoko, MD, Yoshihiko Fujinaka, MD, Nobuhide Kubo, MD, Natsumi Yamashita, MD, Keiji Yoshinaga, MD, PhD, Hiroshi Saeki, MD, PhD, Yasunori Emi, MD, PhD, Yoshihiro Kakeji, MD, PhD, FACS, Ken Shirabe, MD, PhD, FACS, Yoshihiko Maehara, MD, PhD, FACS

Erschienen in: Annals of Surgical Oncology | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Resections for esophageal cancer are invasive, with high mortality and morbidity rates. The object of this study was to clarify the factors associated with in-hospital death while also evaluating any associated historical changes in the characteristics of such deaths.

Methods

The factors associated with mortality were examined by logistic regression analysis in 1106 patients who underwent an esophagectomy for esophageal cancer. The historical changes in the characteristics of in-hospital deaths were also evaluated.

Results

A multivariate analysis revealed that not only undergoing an esophagectomy before 1979, but also a patient’s age (odds ratio 1.070 for every increase in age by year) and an incomplete resection (odds ratio 2.265) were independent factors associated with in-hospital death. The in-hospital mortality rates were 16.1%, 5.8%, 2.5%, and 3.1%, while the 30-day mortality rates were 9.2%, 2.2%, 0.8%, and 0.3% during 1964–1979, the 1980s, the 1990s, and the 2000s, respectively. Eight patients had preoperative comorbidities among 11 patients who died in the hospital after 1997. The mortality rate was 5.5% in patients with any comorbidities, while it was 1.3% in patients without any comorbidities (P = 0.026). The most common direct cause of in-hospital death was previous pulmonary complications; however, cancer progression has recently become the most common cause.

Conclusions

To prevent in-hospital mortality after an esophagectomy, strict indications for surgery and careful perioperative management are important, especially in high-risk patients with advanced esophageal cancer.
Literatur
1.
Zurück zum Zitat Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: a critical review of surgery. Br J Surg. 1980;67:381–90.PubMedCrossRef Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: a critical review of surgery. Br J Surg. 1980;67:381–90.PubMedCrossRef
2.
Zurück zum Zitat Müller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg. 1990;77:845–57.PubMedCrossRef Müller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg. 1990;77:845–57.PubMedCrossRef
3.
Zurück zum Zitat Altorki N, Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg. 2001;234:581–7.PubMedCrossRef Altorki N, Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg. 2001;234:581–7.PubMedCrossRef
4.
Zurück zum Zitat Wu PC, Posner M. The role of surgery in the management of oesophageal cancer. Lancet Oncol. 2003;4:481–8.PubMedCrossRef Wu PC, Posner M. The role of surgery in the management of oesophageal cancer. Lancet Oncol. 2003;4:481–8.PubMedCrossRef
5.
Zurück zum Zitat Jamieson GG, Mathew G, Ludemann R, et al. Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg. 2004;91:943–7.PubMedCrossRef Jamieson GG, Mathew G, Ludemann R, et al. Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg. 2004;91:943–7.PubMedCrossRef
6.
Zurück zum Zitat Orringer MB, Marshall B, Chang AC, et al. Two thousand transhiatal esophagectomies. Changing trends, lessons learned. Ann Surg. 2007;246:363–74.PubMedCrossRef Orringer MB, Marshall B, Chang AC, et al. Two thousand transhiatal esophagectomies. Changing trends, lessons learned. Ann Surg. 2007;246:363–74.PubMedCrossRef
7.
Zurück zum Zitat Siewert JR, Stein HJ, Feith M, et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1000 consecutive resections at a single institution in the Western world. Ann Surg. 2001;234:360–9.PubMedCrossRef Siewert JR, Stein HJ, Feith M, et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1000 consecutive resections at a single institution in the Western world. Ann Surg. 2001;234:360–9.PubMedCrossRef
8.
Zurück zum Zitat Karl RC, Schreiber R, Boulware D, Baker S, Coppola D. Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagectomy. Ann Surg. 2000;231:635–43.PubMedCrossRef Karl RC, Schreiber R, Boulware D, Baker S, Coppola D. Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagectomy. Ann Surg. 2000;231:635–43.PubMedCrossRef
9.
Zurück zum Zitat Japanese Society of Esophageal Diseases. Comprehensive registry of esophageal cancer in Japan. Esophagus. 2005;2:43–69.CrossRef Japanese Society of Esophageal Diseases. Comprehensive registry of esophageal cancer in Japan. Esophagus. 2005;2:43–69.CrossRef
10.
Zurück zum Zitat Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg. 1994;220:364–73.PubMedCrossRef Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg. 1994;220:364–73.PubMedCrossRef
11.
Zurück zum Zitat Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg. 2000;232:225–32.PubMedCrossRef Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg. 2000;232:225–32.PubMedCrossRef
12.
Zurück zum Zitat Shimada H, Matsubara H, Okazumi S, Isono K, Ochiai T. Improved surgical results in thoracic esophageal squamous cell carcinoma: a 40-year analysis of 792 patients. J Gastrointest Surg. 2008,12:518–26.PubMedCrossRef Shimada H, Matsubara H, Okazumi S, Isono K, Ochiai T. Improved surgical results in thoracic esophageal squamous cell carcinoma: a 40-year analysis of 792 patients. J Gastrointest Surg. 2008,12:518–26.PubMedCrossRef
13.
Zurück zum Zitat Morita M, Yoshida R, Ikeda K, et al. Advances in esophageal cancer surgery in Japan: an analysis of 1000 consecutive patients treated at a single institute. Surgery. 2008;143:499–508.PubMedCrossRef Morita M, Yoshida R, Ikeda K, et al. Advances in esophageal cancer surgery in Japan: an analysis of 1000 consecutive patients treated at a single institute. Surgery. 2008;143:499–508.PubMedCrossRef
14.
Zurück zum Zitat Ueda Y, Fujii Y, Udagawa H. Thoracic and cardiovascular surgery in Japan during 2006. Annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2008;56:365–88.PubMedCrossRef Ueda Y, Fujii Y, Udagawa H. Thoracic and cardiovascular surgery in Japan during 2006. Annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2008;56:365–88.PubMedCrossRef
15.
Zurück zum Zitat Kuwano H, Kato H, Nakajima M, et al. Transthoracal partial resection or local excision of small carcinoma with a radical mediastinal lymphadenectomy—proposal of limited operation for postoperative quality of life. Hepatogastroenterology. 2004;51:1631–5.PubMed Kuwano H, Kato H, Nakajima M, et al. Transthoracal partial resection or local excision of small carcinoma with a radical mediastinal lymphadenectomy—proposal of limited operation for postoperative quality of life. Hepatogastroenterology. 2004;51:1631–5.PubMed
16.
Zurück zum Zitat Morita M, Egashira A, Yoshida R, et al. Esophagectomy in patients 80 years of age and older with carcinoma of the thoracic esophagus. J Gastroenterol. 2008;43:345–51.PubMedCrossRef Morita M, Egashira A, Yoshida R, et al. Esophagectomy in patients 80 years of age and older with carcinoma of the thoracic esophagus. J Gastroenterol. 2008;43:345–51.PubMedCrossRef
17.
Zurück zum Zitat Kuwano H, Nishimura Y, Ohtsu A, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus. April 2007 edition: part I. Edited by the Japan Esophageal Society. Esophagus. 2008;5:61–73.CrossRef Kuwano H, Nishimura Y, Ohtsu A, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus. April 2007 edition: part I. Edited by the Japan Esophageal Society. Esophagus. 2008;5:61–73.CrossRef
18.
Zurück zum Zitat International Union Against Cancer. TNM classification of Malignant Tumors. 6th ed. New York: Wiley; 2002. International Union Against Cancer. TNM classification of Malignant Tumors. 6th ed. New York: Wiley; 2002.
19.
Zurück zum Zitat Mariette C, Taillier G, Van Seuningen I, Triboulet JP. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma. Ann Thorac Surg. 2004;78:1177–83.PubMedCrossRef Mariette C, Taillier G, Van Seuningen I, Triboulet JP. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma. Ann Thorac Surg. 2004;78:1177–83.PubMedCrossRef
20.
Zurück zum Zitat Whooley BP, Law S, Murthy SC, Alexandrou A, Wong J. Analysis of reduced death and complication rates after esophageal resection. Analysis of reduced death and complication rates after esophageal resection. Ann Surg. 2001;233:338–44.PubMedCrossRef Whooley BP, Law S, Murthy SC, Alexandrou A, Wong J. Analysis of reduced death and complication rates after esophageal resection. Analysis of reduced death and complication rates after esophageal resection. Ann Surg. 2001;233:338–44.PubMedCrossRef
21.
Zurück zum Zitat Atkins BZ, Shah AS, Hutcheson KA, et al. Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg. 2004;78:1170–6.PubMedCrossRef Atkins BZ, Shah AS, Hutcheson KA, et al. Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg. 2004;78:1170–6.PubMedCrossRef
22.
Zurück zum Zitat Lanuti M, de Delva PE, Maher A, et al. Feasibility and outcomes of an early extubation policy after esophagectomy. Ann Thorac Surg. 2006;82:2037–41.PubMedCrossRef Lanuti M, de Delva PE, Maher A, et al. Feasibility and outcomes of an early extubation policy after esophagectomy. Ann Thorac Surg. 2006;82:2037–41.PubMedCrossRef
23.
Zurück zum Zitat Saeki H, Morita M, Harada N, et al. A survey of the effects of silvestat sodium administration on patients with postoperative respiratory dysfunction. Surg Today. 2010;40:1034–9.PubMedCrossRef Saeki H, Morita M, Harada N, et al. A survey of the effects of silvestat sodium administration on patients with postoperative respiratory dysfunction. Surg Today. 2010;40:1034–9.PubMedCrossRef
24.
Zurück zum Zitat Sato N, Koeda K, Ikeda K, et al. Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg. 2002;236:184–90.PubMedCrossRef Sato N, Koeda K, Ikeda K, et al. Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg. 2002;236:184–90.PubMedCrossRef
25.
Zurück zum Zitat Sugimachi K, Ueo H, Natsuda Y, et al. Cough dynamics in oesophageal cancer prevention of postoperative pulmonary complications;Br J Surg. 1982:69:734–6.PubMedCrossRef Sugimachi K, Ueo H, Natsuda Y, et al. Cough dynamics in oesophageal cancer prevention of postoperative pulmonary complications;Br J Surg. 1982:69:734–6.PubMedCrossRef
26.
Zurück zum Zitat Rizk NP, Bach PB, Schrag D, et al. The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg. 2004;198:42–50.PubMedCrossRef Rizk NP, Bach PB, Schrag D, et al. The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg. 2004;198:42–50.PubMedCrossRef
27.
Zurück zum Zitat Morita M, Yoshida R, Ikeda K, et al. Acute lung injury following an esophagectomy for esophageal cancer, with special reference to the clinical factors and cytokine levels of peripheral blood and pleural drainage fluid. Dis Esophagus. 2008;21:30–6.PubMed Morita M, Yoshida R, Ikeda K, et al. Acute lung injury following an esophagectomy for esophageal cancer, with special reference to the clinical factors and cytokine levels of peripheral blood and pleural drainage fluid. Dis Esophagus. 2008;21:30–6.PubMed
28.
Zurück zum Zitat Kuwano H, Matsushima T, Ikebe M, et al. Mediastinal drainage prevents fatal pyothorax from anastomotic leakage after intrathoracic anastomosis in reconstruction for carcinoma of the esophagus. Surg Gynecol Obstet. 1993;177:131–4.PubMed Kuwano H, Matsushima T, Ikebe M, et al. Mediastinal drainage prevents fatal pyothorax from anastomotic leakage after intrathoracic anastomosis in reconstruction for carcinoma of the esophagus. Surg Gynecol Obstet. 1993;177:131–4.PubMed
29.
Zurück zum Zitat Nagawa H, Seto Y, Nakatsukasa T, Kaizaki S, Muto T. Microvascular anastomosis for additional blood flow after intrathoracic esophageal cancer surgery. Am J Surg. 1997;173:131–3.PubMedCrossRef Nagawa H, Seto Y, Nakatsukasa T, Kaizaki S, Muto T. Microvascular anastomosis for additional blood flow after intrathoracic esophageal cancer surgery. Am J Surg. 1997;173:131–3.PubMedCrossRef
30.
Zurück zum Zitat Law S, Wong K, Kwok K, Chu K, Wong J. Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg. 2004;240:791–800.PubMedCrossRef Law S, Wong K, Kwok K, Chu K, Wong J. Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg. 2004;240:791–800.PubMedCrossRef
31.
Zurück zum Zitat Abunasra H, Lewis S, Beggs L, et al. Predictors of operative death after oesophagectomy for carcinoma. Br J Surg. 2005;92:1029–33.PubMedCrossRef Abunasra H, Lewis S, Beggs L, et al. Predictors of operative death after oesophagectomy for carcinoma. Br J Surg. 2005;92:1029–33.PubMedCrossRef
32.
Zurück zum Zitat Steyerberg EW, Nevellie BA, Koppert LB, et al. Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score. J Clin Oncol. 2006;24:4277–84.PubMedCrossRef Steyerberg EW, Nevellie BA, Koppert LB, et al. Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score. J Clin Oncol. 2006;24:4277–84.PubMedCrossRef
33.
Zurück zum Zitat Bailey SH, Bull DA, Harple DH, et al. Outcomes after esophagectomy: a ten-year prospective cohohot. Ann Thorac Surg. 2003;75:217–22.PubMedCrossRef Bailey SH, Bull DA, Harple DH, et al. Outcomes after esophagectomy: a ten-year prospective cohohot. Ann Thorac Surg. 2003;75:217–22.PubMedCrossRef
34.
Zurück zum Zitat Sugimachi K, Kitamura M, Maekawa S, Matsufuji H, Kai H. Two stage operation for poor-risk patients with carcinoma of the esophagus. J Surg Oncol. 1987;36:105–9.PubMedCrossRef Sugimachi K, Kitamura M, Maekawa S, Matsufuji H, Kai H. Two stage operation for poor-risk patients with carcinoma of the esophagus. J Surg Oncol. 1987;36:105–9.PubMedCrossRef
35.
Zurück zum Zitat Tsutsui S, Morita M, Kuwano H, et al. Influence of preoperative treatment and surgical operation on immune function of patients with esophageal carcinoma. J Surg Oncol. 1992;49:176–81.PubMedCrossRef Tsutsui S, Morita M, Kuwano H, et al. Influence of preoperative treatment and surgical operation on immune function of patients with esophageal carcinoma. J Surg Oncol. 1992;49:176–81.PubMedCrossRef
36.
Zurück zum Zitat Morita M, Kuwano H, Ohno S, Furusawa M, Sugimachi K. Characteristics and sequence of the recurrent patterns after curative esophagectomy for squamous cell carcinoma. Surgery. 1994;116:1–7.PubMed Morita M, Kuwano H, Ohno S, Furusawa M, Sugimachi K. Characteristics and sequence of the recurrent patterns after curative esophagectomy for squamous cell carcinoma. Surgery. 1994;116:1–7.PubMed
37.
Zurück zum Zitat Kato H, Miyazaki T, Nakajima M, et al. Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma. Br J Surg. 2004;91:1004–9.PubMedCrossRef Kato H, Miyazaki T, Nakajima M, et al. Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma. Br J Surg. 2004;91:1004–9.PubMedCrossRef
38.
Zurück zum Zitat Dimick JB, Cattaneo SM, Lipsett PA, Pronovost PJ, Heitmiller RF. Hospital volume is related to clinical and economic outcomes of esophageal resections in Maryland. Ann Thorac Surg. 2001;72:334–9.PubMedCrossRef Dimick JB, Cattaneo SM, Lipsett PA, Pronovost PJ, Heitmiller RF. Hospital volume is related to clinical and economic outcomes of esophageal resections in Maryland. Ann Thorac Surg. 2001;72:334–9.PubMedCrossRef
Metadaten
Titel
In-Hospital Mortality After a Surgical Resection for Esophageal Cancer: Analyses of the Associated Factors and Historical Changes
verfasst von
Masaru Morita, MD, PhD, FACS
Tomonori Nakanoko, MD
Yoshihiko Fujinaka, MD
Nobuhide Kubo, MD
Natsumi Yamashita, MD
Keiji Yoshinaga, MD, PhD
Hiroshi Saeki, MD, PhD
Yasunori Emi, MD, PhD
Yoshihiro Kakeji, MD, PhD, FACS
Ken Shirabe, MD, PhD, FACS
Yoshihiko Maehara, MD, PhD, FACS
Publikationsdatum
01.06.2011
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 6/2011
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1502-5

Weitere Artikel der Ausgabe 6/2011

Annals of Surgical Oncology 6/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.